Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Asset Utilization Ratio: 2011-2024

Historic Asset Utilization Ratio for Ani Pharmaceuticals (ANIP) over the last 14 years, with Dec 2024 value amounting to 0.56.

  • Ani Pharmaceuticals' Asset Utilization Ratio rose 19.48% to 0.60 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.60, marking a year-over-year increase of 19.48%. This contributed to the annual value of 0.56 for FY2024, which is 4.00% down from last year.
  • Ani Pharmaceuticals' Asset Utilization Ratio amounted to 0.56 in FY2024, which was down 4.00% from 0.58 recorded in FY2023.
  • Over the past 5 years, Ani Pharmaceuticals' Asset Utilization Ratio peaked at 0.58 during FY2023, and registered a low of 0.35 during FY2021.
  • For the 3-year period, Ani Pharmaceuticals' Asset Utilization Ratio averaged around 0.52, with its median value being 0.56 (2024).
  • In the last 5 years, Ani Pharmaceuticals' Asset Utilization Ratio decreased by 22.80% in 2021 and then skyrocketed by 41.59% in 2023.
  • Yearly analysis of 5 years shows Ani Pharmaceuticals' Asset Utilization Ratio stood at 0.45 in 2020, then fell by 22.80% to 0.35 in 2021, then grew by 17.82% to 0.41 in 2022, then surged by 41.59% to 0.58 in 2023, then fell by 4.00% to 0.56 in 2024.